Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions

The relevance of biological therapies for an increasing number of conditions is on the rise. Following the expiry of the initial period of market exclusivity, many of these successful therapies have seen the arrival of biosimilars on the market. The clear identification of the precise medicine respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Correia Pinheiro, Luis, Giezen, Thijs J., Wolff‐Holz, Elena, Weise, Martina, Laslop, Andrea, Hidalgo‐Simon, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292214/
https://www.ncbi.nlm.nih.gov/pubmed/34472087
http://dx.doi.org/10.1002/cpt.2411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292214/
https://www.ncbi.nlm.nih.gov/pubmed/34472087
http://dx.doi.org/10.1002/cpt.2411

Ejemplares similares